Marshall Brachman
Marshall Brachman is a lobbying firm that has earned $6.2M in lobbying income across 240 filings, representing 18 clients over 8 years (2018–2025). The firm employs 1 lobbyist across 22 policy issue areas.
🤖
AI Overview
Marshall Brachman has earned $6.2M in lobbying income across 240 filings, representing 18 clients. It is an active participant in federal lobbying. across 22 policy areas. Active from 2018 to 2025.
$6.2M
Total Income
18
Clients
1
Lobbyists
240
Filings
Income by Year
| Year | Lobbying Income |
|---|---|
| 2018 | $748K |
| 2019 | $770K |
| 2020 | $766K |
| 2021 | $614K |
| 2022 | $928K |
| 2023 | $1.1M |
| 2024 | $695K |
| 2025 | $617K |
Clients (18)
Healthpeak Properties, INC. FKA Physicians Realty TrustOklahoma Heart HospitalEdmund Optics INCLockheed Martin Aeronautic SectorZions BancorpCamelbak Products CorpBaylor Scott and White Health -- Formerly Baylor Health Care SystemEncoura (Formerly Nat'l Research Ctr for College and University Admissions)Cardiology Advocacy AllianceW. David HemingwayDun and Bradstreet, INC.Grant Thornton Advisors LLC FKA Grant Thornton LLPHeartplace, P.A.Cardiovascular Associates of the Delaware ValleyVirginia Cardiovascular SpecialistsCardiology Consultants of PhiladelphiaSouth Carolina Heart Center LPAcademic Programs International, LLC
Lobbyists (1)
Issue Areas (22)
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Foreign Governments Are Lobbying Congress
1,000+ foreign entities from 50+ countries lobby the US government.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.